“Our most important finding was that a simple educational intervention significantly decreased the number of sunburns in operational engineers,” said Sonia Duffy, PhD. “Text messages and mailed sunscreen further improved outcomes, but education had the largest effect."
Dr. Ameer and his colleagues incorporated A5G81 into an antioxidant hydrogel bandage they had previously developed. The bandage counters inflammation because of its antioxidant nature. The hydrogel is thermally responsive—it is a liquid when applied to the wound bed, then rapidly solidifies into a gel when exposed to body temperature.
“I think the number one thing is that we are experts . . . we are feeling, as dermatologists, a little bit under attack right now. I think it’s really important for us to own this space and be the experts when it comes to skin, hair, nails, aesthetic dermatology, and medical dermatology,” said Dr. Julia Carroll, director and dermatologist at Compass Dermatology in Toronto.
“Our study shows that age is an important factor to consider when administering immunotherapy to melanoma patients,” said Ashani Weeraratna, Ph.D. “A combination approach to deplete immune suppressive cells in combination with checkpoint blockade therapy might benefit younger patients, although further studies will be required to evaluate more broadly the potential immune toxicities in this approach.”
“Dermatologists are used to public awareness about skin cancer and sun protection, so maybe we can go beyond that and see where dermatologists can interact with their communities, or provide programs for their communities,” said Dr. Cheryl Rosen, head of dermatology at the University Health Network in Toronto in an interview with The Chronicle.
Within a year, 14.4% of patients on spironolactone and 13.4% of patients on antibiotics had switched to different treatments. According to researchers, these results suggest that the two therapies have the same efficacy.
Study authors note the paper represents some of the first published reliable information from a racially diverse population about who likely develops this chronic condition, which is characterized by intensely itchy nodules that develop on the arms and legs that can generalize throughout the body.
Guselkumab, a biologic therapy that is part of a new class of agents targeting interleukin (IL)-23 without blocking IL-12, was approved in Nov. 2017 by Health Canada for the treatment of moderate to severe plaque psoriasis in adults.
The new therapy is more precisely targeted than some earlier biologics, Dr. Melinda Gooderham said during an interview with DERM.city.She was a researcher involved in clinical tr...
Investigators found significant differences between the outdoor professions, with mountain guides at the highest risk for NMSC. As well, substantial differences between the professions were seen in skin cancer screening rates—indoor worker 61.4%, mountain guides 57.8%, farmers 31.9%, and gardeners 27.6%—daily ultraviolet radiation exposure during work, and protective behaviour including sunscreen use during...
“The research alerts us to the reality that people with rosacea can feel like they are stuck in an unwinnable situation . . . [we need to] ensure people are comfortable talking about the impacts this illness can have on their lives,” said Dr. Jerry Tan, adjunct professor, Western University, Windsor, Ont.